LPCAT4 Knockdown Alters Barrier Integrity and Cellular Bioenergetics in Human Urothelium.

The urothelium forms a protective lining in the urinary tract, balancing mechanical resilience with a tight barrier function. While glycerophospholipids are known to influence membrane structure and signaling, their specific roles in urothelial differentiation remain unclear. Prior research has shown that PPARγ regulates urothelial differentiation, but the contribution of lipid metabolism is less defined. No prior work had resolved how lipid remodeling might support barrier integrity. This gap motivated the current investigation into lipidomic and transcriptomic changes during urothelial differentiation. The study aimed to clarify how lipid metabolism intersects with barrier function and cellular bioenergetics. Previous studies did not explore the role of LPCAT4 in urothelial function. The absence of such data left a gap in understanding how lipid remodelling affects epithelial resilience. This paper addresses that uncertainty by examining the impact of LPCAT4 knockdown on urothelial properties.

The study aimed to investigate the role of glycerophospholipids in urothelial barrier function. Specifically, it sought to determine how lipid metabolism influences urothelial differentiation and barrier integrity. The researchers focused on LPCAT4, a gene upregulated during differentiation. They hypothesized that this gene might mediate changes in lipid composition and cellular function. The study also aimed to explore how lipidomic and transcriptomic data could be combined to understand tissue homeostasis. The motivation stemmed from the lack of clarity on how lipid remodeling supports barrier resilience. By integrating lipidomic and transcriptomic approaches, the authors aimed to uncover new regulatory mechanisms. This work sought to bridge the gap between lipid metabolism and epithelial function.

The researchers used lipidomic and transcriptomic profiling to study urothelial differentiation. They analyzed changes in lipid composition and gene expression during differentiation. LPCAT4 knockdown was achieved using RNA interference in cultured urothelial cells. Trans-epithelial electrical resistance was measured to assess barrier integrity. Wounding assays were performed to evaluate barrier restoration after injury. Transcriptomic analysis focused on genes related to lipid metabolism and bioenergetics. The study also included pharmacological inhibition of PKC and TSPO to validate predicted effects. These methods allowed the authors to link lipid changes to functional outcomes in urothelial cells.

LPCAT4 was found to be upregulated 5-fold during urothelial differentiation. Knockdown of LPCAT4 reduced proliferation rates in cultured cells. Differentiated LPCAT4 knockdown cultures showed elevated trans-epithelial electrical resistance. However, these cultures exhibited delayed barrier restoration after wounding. Specific reduction in 18:1 PC fatty acyl chains was observed in knockdown cells. Transcriptomic analysis suggested reduced DAG availability due to LPC deficiency. This was linked to decreased PKC activity and TSPO abundance. These predictions were confirmed using PKC and TSPO inhibitors, supporting the role of lipid mediators in barrier function.

The findings suggest that lipid mediators play an integral role in urothelial barrier function. The study highlights the importance of LPCAT4 in lipid remodeling during differentiation. Transcriptomic and lipidomic data together reveal how lipid metabolism influences barrier integrity. The results indicate that reduced DAG availability may limit PKC activity in urothelial cells. TSPO abundance was also affected, potentially impacting endogenous ATP levels. These effects were confirmed using targeted inhibition experiments. The study supports the use of combined lipidomic and transcriptomic analyses to understand tissue homeostasis. The authors propose that lipid metabolism is a key regulator of urothelial function.